Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions.
This review critically reappraises recent scientific evidence concerning central leptin insufficiency versus leptin resistance formulations to explain metabolic and neural disorders resulting from subnormal or defective leptin signaling in various sites in the brain. Research at various fronts to unravel the complexities of the neurobiology of leptin is surveyed to provide a comprehensive account of the neural and metabolic effects of environmentally imposed fluctuations in leptin availability at brain sites and the outcome of newer technology to restore leptin signaling in a site-specific manner. The cumulative new knowledge favors a unified central leptin insufficiency syndrome over the, in vogue, central resistance hypothesis to explain the global adverse impact of deficient leptin signaling in the brain. Furthermore, the leptin insufficiency syndrome delineates a novel role of leptin in the hypothalamus in restraining rhythmic pancreatic insulin secretion while concomitantly enhancing glucose metabolism and non-shivering thermogenic energy expenditure, sequelae that would otherwise promote fat accrual to store excess energy resulting from consumption of energy-enriched diets. A concerted effort should now focus on development of newer technologies for delivery of leptin or leptin mimetics to specifically target neural pathways for remediation of diverse ailments encompassing the central leptin insufficiency syndrome.
Kalra
Satya P
SP
Department of Neuroscience, University of Florida McKnight Brain Institute, PO Box 100244, Gainesville, FL 32610-0244, USA. skalra@mbi.ufl.edu <skalra@mbi.ufl.edu>
D000818:Animals; D006801:Humans; D020738:Leptin / Q000172:deficiency* / Q000378:metabolism*; D008659:Metabolic Diseases / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D009422:Nervous System Diseases / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D009765:Obesity / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D013577:Syndrome
D020738:Leptin